Clinical trial · Observational
Exploration of Patient Self-medication Practices During and After Cancer in France
Exploration of Patient Self-medication Practices During and After Cancer in France: Cross-sectional Observational Study With Online Response
NCT05156931CI-TRIAL-00121050CASEMEcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to assess the patient self-medication practices during and after cancer in France, using an online questionnaire
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Self-medication | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Self-medication
- timeFrame
- day 1
- description
- declaration of a practice of self-medication
Secondary outcomes (5)
- measure
- Class of products used in self-medication
- timeFrame
- day 1
- description
- non-prescription medicine, herbal medicine, aromatherapy, homeopathy, and food supplements
- measure
- Indication for self-medication
- timeFrame
- day 1
- description
- For treatment of side-effects, improvements in anti-cancer effects
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Past or active cancer Exclusion Criteria: * Speaking French * Not living in France
References
Publications (1)
- RESULTMaraud J, Bedhomme S, Pereira B, Trevis S, Jary M, Balayssac D. Self-Medication during and after Cancer: A French Nation-Wide Cross-Sectional Study. Cancers (Basel). 2023 Jun 15;15(12):3190. doi: 10.3390/cancers15123190. PMID 37370800